Tag Archives: early stage research

Ask any biotech professional about Stanley Cohen and Herbert Boyer and they will tell you about their incredible contributions to modern biotechnology. But what about Roland Tibbetts? My guess is there are more than a few quizzical looks out there. So who is Roland Tibbetts? In many ways, Roland Tibbetts did for the commercialization of biotechnology, what Cohen and Boyer did for the science. He is the creator of the Small Business Innovation Research (SBIR) Read More >

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in recent months, pooling resources and expertise in an attempt to source and develop the most successful drugs. BIO Executive Vice President Alan Eisenberg moderated It Takes a Village: The New Pharma-VC Model for Biotech Investing, a panel discussion about these new funding models, during the opening plenary session at the 2012 BIO Investor Forum. In the past, venture capital could Read More >

The BIO Technology Transfer Symposium dissects recent academia-industry collaborations and evaluates the value in early stage biotechnology investments. The event occurs in San Francisco on October 8th ahead of the BIO Investor Forum and provides a unique opportunity for bringing academia, industry, and the investment community together. This year’s event is headlined by Tom Thornton from the Cleveland Clinic, a leading academic medical center. The first panel highlights the collaboration between Duke Translational Research Institute Read More >